{"title":"Development of a surrogate model for predicting atherosclerotic plaque progression based on agent based modeling data.","authors":"Lemana Spahić, Nenad Filipović","doi":"10.1177/09287329241309771","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Atherosclerosis of the coronary arteries is a chronic, progressive condition characterized by the buildup of plaque within the arterial walls. Coronary artery disease (CAD), more specifically coronary atherosclerosis (CATS), is one of the leading causes of death worldwide. Computational modeling frameworks have been used for simulation of atherosclerotic plaque progression and with the advancement of agent-based modeling (ABM) the simulation results became more accurate. However, there is a need for optimization of resources for predictive modeling, hence surrogate models are being built to substitute lengthy computational models without compromising the results.</p><p><strong>Objective: </strong>This study explores the development of a surrogate model for atherosclerotic plaque progression using ABM simulation data.</p><p><strong>Method: </strong>The dataset used for this study contains samples from latin-hypercube sampling based generated simulation parameters used in conjunction with 15 patient-specific geometries and corresponding plaque progression data. The developed surrogate model is based on deep learning using artificial neural networks (ANN).</p><p><strong>Results: </strong>The surrogate model achieved an accuracy of 95.4% in benchmarking with the ABM model it was built upon which indicates the robustness of the framework.</p><p><strong>Conclusion: </strong>Adoption of surrogate models with high accuracy in practice opens an avenue for utilization of high-fidelity decision support systems for predicting atherosclerotic plaque progression in real-time.</p>","PeriodicalId":48978,"journal":{"name":"Technology and Health Care","volume":" ","pages":"9287329241309771"},"PeriodicalIF":1.4000,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Technology and Health Care","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1177/09287329241309771","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Atherosclerosis of the coronary arteries is a chronic, progressive condition characterized by the buildup of plaque within the arterial walls. Coronary artery disease (CAD), more specifically coronary atherosclerosis (CATS), is one of the leading causes of death worldwide. Computational modeling frameworks have been used for simulation of atherosclerotic plaque progression and with the advancement of agent-based modeling (ABM) the simulation results became more accurate. However, there is a need for optimization of resources for predictive modeling, hence surrogate models are being built to substitute lengthy computational models without compromising the results.
Objective: This study explores the development of a surrogate model for atherosclerotic plaque progression using ABM simulation data.
Method: The dataset used for this study contains samples from latin-hypercube sampling based generated simulation parameters used in conjunction with 15 patient-specific geometries and corresponding plaque progression data. The developed surrogate model is based on deep learning using artificial neural networks (ANN).
Results: The surrogate model achieved an accuracy of 95.4% in benchmarking with the ABM model it was built upon which indicates the robustness of the framework.
Conclusion: Adoption of surrogate models with high accuracy in practice opens an avenue for utilization of high-fidelity decision support systems for predicting atherosclerotic plaque progression in real-time.
期刊介绍:
Technology and Health Care is intended to serve as a forum for the presentation of original articles and technical notes, observing rigorous scientific standards. Furthermore, upon invitation, reviews, tutorials, discussion papers and minisymposia are featured. The main focus of THC is related to the overlapping areas of engineering and medicine. The following types of contributions are considered:
1.Original articles: New concepts, procedures and devices associated with the use of technology in medical research and clinical practice are presented to a readership with a widespread background in engineering and/or medicine. In particular, the clinical benefit deriving from the application of engineering methods and devices in clinical medicine should be demonstrated. Typically, full length original contributions have a length of 4000 words, thereby taking duly into account figures and tables.
2.Technical Notes and Short Communications: Technical Notes relate to novel technical developments with relevance for clinical medicine. In Short Communications, clinical applications are shortly described. 3.Both Technical Notes and Short Communications typically have a length of 1500 words.
Reviews and Tutorials (upon invitation only): Tutorial and educational articles for persons with a primarily medical background on principles of engineering with particular significance for biomedical applications and vice versa are presented. The Editorial Board is responsible for the selection of topics.
4.Minisymposia (upon invitation only): Under the leadership of a Special Editor, controversial or important issues relating to health care are highlighted and discussed by various authors.
5.Letters to the Editors: Discussions or short statements (not indexed).